Filtered By:
Management: Medicare
This page shows you your search results in order of relevance. This is page number 2.
Order by Relevance | Date
Total 238 results found since Jan 2013.
Trends in inferior turbinate surgery: analysis of patients using the Medicare database
International Forum of Allergy&Rhinology,Volume 8, Issue 10, Page 1169-1174, October 2018.
Source: International Forum of Allergy and Rhinology - July 10, 2018 Category: Allergy & Immunology Authors: Mitchell Anderson,
Jonathan Liang Source Type: research
Assessment of adherence and asthma medication ratio (AMR) for a once-daily and twice-daily inhaled corticosteroid/long acting beta agonist (ICS/LABA) for asthma
ConclusionsAdherence and treatment persistence were low in both cohorts, however, patients initiating once-daily FF/VI were more likely to be adherent, have an AMR ≥0.5, and were less likely to discontinue therapy compared with patients initiating twice-daily BUD/F. (GSK Study HO1617302/206482)
Source: The Journal of Allergy and Clinical Immunology: In Practice - January 11, 2019 Category: Allergy & Immunology Source Type: research
Assessment of Adherence and Asthma Medication Ratio for a Once-Daily and Twice-Daily Inhaled Corticosteroid/Long-Acting β-Agonist for Asthma
ConclusionsAdherence and treatment persistence were low in both cohorts; however, patients initiating once-daily FF/VI were more likely to be adherent, have an AMR of greater than or equal to 0.5, and were less likely to discontinue therapy compared with patients initiating twice-daily BUD/F (GlaxoSmithKline Study HO1617302/206482).
Source: The Journal of Allergy and Clinical Immunology: In Practice - May 9, 2019 Category: Allergy & Immunology Source Type: research
Omalizumab treatment patterns among patients with asthma in the US Medicare population
ConclusionOver 60% of Medicare patients with asthma continued and were adherent to omalizumab over 12-month follow-up. Patient age, LIS status, and the numbers of evaluation and management physician visits were among factors associated with treatment adherence and discontinuation.
Source: The Journal of Allergy and Clinical Immunology: In Practice - July 21, 2019 Category: Allergy & Immunology Source Type: research
Race and Asthma Outcomes in Older Adults: Results from the National Asthma Survey
ConclusionsRacial differences in asthma outcomes persist despite controlling for multiple social determinants of health and access to health insurance through Medicare. Minority patients were more likely to visit the ER but less likely to report frequent daytime symptoms. These findings indicate that comprehensive strategies to address assessment, monitoring, and treatment are needed to decrease health disparities.
Source: The Journal of Allergy and Clinical Immunology: In Practice - February 6, 2020 Category: Allergy & Immunology Source Type: research
Real-world effectiveness of mepolizumab in patients with severe asthma and associated comorbidities
CONCLUSION: Mepolizumab treatment provided real-world clinical benefits in patients.PMID:34038773 | DOI:10.1016/j.anai.2021.05.021
Source: Annals of Allergy, Asthma and Immunology - May 26, 2021 Category: Allergy & Immunology Authors: Thomas Casale Nestor A Molfino Jared Silver Michael Bogart Elizabeth Packnett Donna McMorrow Joanne Wu Beth Hahn Source Type: research
The Future of Health Care - A Look Forward for the Allergist
It comes as no surprise that the delivery and payment for healthcare services in the United States is constantly changing. Recently, the federal government through the Centers for Medicare and Medicaid Services Innovation (CMMI) was instructed to work toward value-based healthcare delivery models.1 CMMI was developed to address these challenges through creativity and innovation.2 The allergy-immunology specialty is small (less than 6,000 physicians), but our perspective of our nation's healthcare delivery system may be instructive for all of medicine as we adapt to these and other disruptive changes in healthcare.
Source: Annals of Allergy, Asthma and Immunology - September 23, 2021 Category: Allergy & Immunology Authors: James M. Tracy, J. Allen Meadows, Stephen Imbeau, Bill Finerfrock, James L. Sublett Source Type: research
The future of health care
It comes as no surprise that the delivery and payment for health care services in the United States are constantly changing. Recently, the federal government, through the Centers for Medicare and Medicaid Services Innovation (CMMI), was instructed to work toward value-based health care delivery models.1 The CMMI was developed to address these challenges through creativity and innovation.2 The allergy-immunology specialty is small (less than 6000 physicians), but our perspective of our nation's health care delivery system may be instructive for all the medicine as we adapt to these and other disruptive changes in health care.
Source: Annals of Allergy, Asthma and Immunology - September 23, 2021 Category: Allergy & Immunology Authors: James M. Tracy, J. Allen Meadows, Stephen Imbeau, Bill Finerfrock, James L. Sublett Tags: Perspective Source Type: research
Medication Adherence in Medicare Enrolled Older Adults with Asthma Before and During the COVID-19 Pandemic
CONCLUSION: Adherence to asthma controller medications significantly decreased during the COVID-19 pandemic among Medicare enrolled patients with asthma. Patients with markers for more severe asthma, overuse of albuterol, and a 90-day supply of controller medications were more likely to have high adherence. These findings can be used to identify opportunities to improve adherence and prescribing among adult patients with asthma.PMID:35227901 | DOI:10.1016/j.anai.2022.02.010
Source: Annals of Allergy, Asthma and Immunology - March 1, 2022 Category: Allergy & Immunology Authors: Olivia L Ramey Armando Silva Almod óvar Milap C Nahata Source Type: research
A National Cancer Database Analysis of Sinonasal Malignant Myoepithelial Carcinoma Outcomes
DISCUSSION: MECA of the sinonasal cavity is a rare tumor with poorly understood behavior. Data from the NCDB suggests that it is a relatively aggressive tumor with surgical management associated with better outcomes. This analysis is limited by the small sample size and further research into optimal treatment regimens is needed.PMID:35971225 | DOI:10.1177/19458924221121419
Source: American Journal of Rhinology and Allergy - August 16, 2022 Category: ENT & OMF Authors: Jacob G Eide Rijul S Kshirsagar Jason A Brant James N Palmer Nithin D Adappa Source Type: research
